Skip to main content
Clinical Trials/ACTRN12620000952943
ACTRN12620000952943
Recruiting
未知

Breathing and anxiety: Understanding the effect of serotonin re-uptake inhibitors on the possible miscommunication between brain and body in individuals with clinical levels of anxiety

niversity of Otago0 sites105 target enrollmentSeptember 24, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Anxiety
Sponsor
niversity of Otago
Enrollment
105
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 24, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Both groups:
  • Diagnosed with any clinically significant anxiety disorder AND prescribed with a course of an SSRI by their medical practitioner
  • Male or female aged between 18 and 45 years
  • Ability to provide written and informed consent
  • Ability to adhere to the study protocol
  • Exposure group only: Either have not started or be within the first 7 days of beginning their SSRI medication
  • Control group only: Have been taking their SSRI medication consistently for at least 3 months

Exclusion Criteria

  • Evidence of severe acute or chronic medical disorders, including a neurological disorder, current or past history of a severe brain injury or severe respiratory disorder e.g. severe asthma, chronic obstructive pulmonary disease etc.
  • Past or current diagnoses of schizophrenia, bipolar disorder, drug addiction or psychosis
  • Colour blindness
  • Female patients who are pregnant or breastfeeding
  • Current significant suicidal ideation
  • Participants must be free of recreational drug and alcohol use at the time of testing

Outcomes

Primary Outcomes

Not specified

Similar Trials